Abstract
1-(2-methoxy phenyl) piperazine fragment of WAY100635 or its phenolic analogue, derived from DWAY is used to design the desired structure of 5HT1A receptor imaging agents. In this study a DWAY analogue was labeled with 99mTc-nitrido ([99mTcN]2+) core via dithiocarbamate. 2-(piperazin-1-yl) phenol dithiocarbamate was synthesized by the reaction of 2-(piperazin-1-yl) phenol with an equivalent amount of carbon disulfide in KOH solution then radiolabeled with 99mTc-nitrido core. The final complex was characterized by HPLC and its radiochemical purity was more than 90 %. In vitro stability studies have shown the complex was stable at least 4 h after labeling at room temperature. The n-octanol/water partition coefficient experiment demonstrated log p = 1.34 for 99mTcN–OHPP–DTC. Biodistribution results showed that radio tracer had moderate brain uptake (0.39 ± 0.03 %ID/g at 15 min and 0.29 ± 0.02 %ID/g at 120 min) and good retention, suggesting that this complex may lead to a further development of a radiotracer with specific binding to 5-HT1A receptor.
Similar content being viewed by others
References
Passchier J, Waarde AV (2001) Eur J Nucl Med 28:113
Halldin C, Gulyas B, Langer O, Fared Q (2001) J Nucl Med 45:139
Aznavour N, Zimmer L (2007) Neuropharmacology 52:695
Farde L, Ito H, Swahn CG, Pike VW, Halldin C (1998) J Nucl Med 39:1965
Lang L, Jagoda E, Schmall B, Vuong BK, Adams HR, Nelson DL, Carson RE, Eckelman WC (1999) J Med Chem 42:1576
Garcia R, Xavier C, Paulo A, Santos I, Kniess T, Bergmann R, Wust F (2005) J Label Compd Radiopharm 48:301
Le-Bars D, Lemaire C, Ginovart N, Plenevaux A, Aerts J, Brihaye C, Hassoun W, Leviel V, Mekhsian P, Weissmann D, Pujol JF, Luxen A, Comar D (1998) Nucl Med Biol 25:343
Pike VW, Halldin C, Wikstrom H, Marchais S, McCarron JA, Sandell J, Nowicki B, Swahn CG, Osman S, Hume SP (2000) Nucl Med Biol 27:449
Sanabria-Bohorquez SM, Biver F, Damhaut P, Wikler D, Veraart C, Goldman S (2002) Eur J Nucl Med 29:76
Vandecapelle M, Dumont F, Vos FD, Strijckmans K, Leysen D, Audenaert K, Dierckx R, Slegers G (2004) J Label Compd Radiopharm 47:531
Parsey RV, Belanger MJ, Sullivan GM, Simpson NR, Stabin MG, Van Heertum R, Mann JJ (2005) J Nucl Med 46:614
Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Jchise M, Innis RB, Pike VW (2006) J Nucl Med 47:345
Papagiannopoulou D, Pirmettis I, Tsoukalas C, Nikoladou L, Dros-sopoulou G, Dalla C, Pelecanou M, Papadopoulou-Daifotis Z, Papa-dopoulos M, Chiotellis E (2002) Nucl Med Biol 29:825
Heimbold I, Drews A, Syhre R, Kretzschmar M, Pietzsch HJ, Johannsen B (2002) Eur J Nucl Med 29:82
Heimbold I, Drews A, Kretzschmar M, Varnas K, Hall H, Halldin C, Syhre R, Kraus W, Pietzsch HJ, Seifert S (2002) Nucl Med Biol 29:375
Leon A, Rey A, Mallo L, Pirmettis I, Papadopoulos M, Leon E, Pa-gano M, Manta E, Incerti M, Raptopoulou C (2002) Nucl Med Biol 29:217
Bolzati C, Mahmood A, Malago E, Uccelli L, Boschi A, Jones AG, Refosco F, Duatti A, Tisato F (2003) Bioconjug Chem 14:1231
Baldas J, Bonnyman J (1985) Int J Appl radiat Isot 35:133
Pasqualini R, Duatti A, Bellande E, Comazzi V, Brucato V, Hoffschir D, Fagret D, Comet M (1994) J Nucl Med 35:334
Dischino D, In Nunn AD (1992) Radiopharmaceuticals: chemistry and pharmacology. Marcel Decker Inc, New York, pp 1–35
Zhang JB, Wang XB, Liu J (2005) Appl Radiat Isot 62:33
Chu TW, Li RJ, Hu SW, Wang Y, Liu XQ, Wang XY (2004) J Radioanal Nucl Chem 261:199
Pike VW, Halldin C, McCarron JA, Lundkvisit C, Hiani E, Olsson H, Hume SP, Karlsson P, Osman S, Swahn CG, Hall H, Wikstrom H, Mensonidas M, Poole KG, Farde L (1998) Eur J Nucl Med Mol Imaging 25:338
Andree B, Halldin C, Pike VW, Gunn RN, Olsson H, Farde L (2002) J Nucl Med 43:292
Defraiteur C, Lemaire C, Luxen A, Plenevaux A (2006) Nucl Med Biol 33:667
Baldas J, Boas JF, Colmanet SF, Ivanov Z, Williams GA (1993) Radiochim Acta 63:111
Nicholson T, Kramer DJ, Davison A, Jones AG (2001) Inorg Chim Acta 316:110
Pasqualini R, Duatti A (1992) J Chem Soc Chem Commun 18:1354
Cliffe lA (2000) Nucl Med Biol 27:441
Kung HF, Kim HJ, Kung MP, Meegalla SK, Plossl K, Lee HK (1996) Eur J Nucl Med Mol Imaging 23:1527
Kung HF (2001) Nucl Med Biol 28:505
Acknowledgments
The authors wish to thank Mr. Mirfallah and Mr. Talebi of the radioisotope department (AEOI) for providing sodium pertechnetate and assistance in quality control tests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erfani, M., Hassanzadeh, L., Ebrahimi, S.E.S. et al. 99mTc-labeling of a dithiocarbamate-DWAY fragment using [99mTcN]2+ core for the preparation of potential 5HT1A receptor imaging agents. J Radioanal Nucl Chem 295, 1783–1788 (2013). https://doi.org/10.1007/s10967-012-2298-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-012-2298-5